Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypokalemia after PEG-asc bowel cleansing
NL-OMON21089Recruiting
- Sponsor
- Atrium Medical Center
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of polyethylene glycol plus ascorbate (2 arms), sponsored by Atrium Medical Center. Primary endpoints: Prevalence of hypokalemia prior to bowel cleansing with PEG-asc and Prevalence of hypokalemia after bowel cleansing with PEG-asc. Started May 2015; status: recruiting.
02
Drugs
polyethylene glycol plus ascorbate
Beyond the preview
Go deeper on NL-OMON21089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21089.